Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about Laverdia-CA1, as well as indolent lymphoma in this interview with dvm360 ...
This CE will discuss how Laverdia CA-1 (verdinexor tabs) fit into treatment of dogs with lymphoma. We will discuss the mechanism of action, dosing, adverse events and efficacy of this novel agent.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback